Investors

IR Home
Events & Presentations
Corporate Governance
Financial Information
Stock Information
Investor FAQs
Press Releases
Investor Contacts
- Investor Emails Alerts
- RSS Feeds

Home › Home › Press Releases

Press Releases

Normal

Press Release RSS Feed (opens in new window)

Press release year list 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

February 13, 2020

Ironwood Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2019 Results, Exceeding Full Year 2019 Guidance; Provides Full Year 2020 Guidance

January 30, 2020

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2019 Investor Update Call

January 22, 2020

Ironwood and Allergan Announce Settlement with Teva Resolving LINZESS® (linaclotide) Patent Litigation

January 6, 2020

Ironwood and Allergan Announce Settlement Resolving LINZESS® (linaclotide) Patent Litigation

January 2, 2020

Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

Investor Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Ironwood Pharmaceuticals, Inc., we strive to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Ironwood Pharmaceuticals, Inc. to send you the requested Investor Email Alert updates.

* Required

Email Address *

Mailing Lists *

News

Events & Presentations

SEC Filings

End of Day Stock Quote

Quarterly Reports

Annual Reports



Enter the code shown above.
*

Email Alert Sign Up Confirmation

Our Company

Our Product
- Discovery of Linaclotide

Our Pipeline
- IW-3718
- MD-7246

Partnerships

Patients

Join Us
- Open Positions
- HR Policies

Investors

Media

Linkedin
Twitter

Privacy Policy
Terms of Use
Site Map
Contact Us

LINZESS®, CONSTELLA®, IRONWOOD® and their associated logos are trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks referred to herein are the property of their respective owners. All rights reserved.